Oct 16, 2025 05:15
MIRA - MIRA Pharmaceuticals, Inc. Common Stock
Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
---|---|---|---|---|---|---|---|
1.78 -0.21 (-11.78%) | 0.0 (0.0%) | 0.0 (0.0%) | -0.02 (-1.55%) | -0.11 (-6.18%) | -0.12 (-7.08%) | --- | -0.11 (-6.18%) |
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Market
Earnings & Ratios
- Basic EPS:
- -0.09
- Diluted EPS:
- -0.09
- Basic P/E:
- -17.4478
- Diluted P/E:
- -17.4478
- RSI(14) 1m:
- 24.08
- VWAP:
- 1.57
- RVol:
- 0.5099
Events
Period | Kind | Movement | Occurred At |
---|
Related News
Aug 12, 2025 17:00
May 08, 2025 11:16
Feb 06, 2025 10:00
Mar 27, 2024 12:14
Mar 08, 2024 18:47
Mar 08, 2024 13:23
Feb 05, 2024 17:56
Nov 27, 2023 18:41
Nov 22, 2023 19:03